Lu and colleagues suggested that TfR1 is upregulated at the early stage of AD in the cortex and hippocampus of APP/PS1 Tg mice, whereas the expression of TfR1 begins to decrease with disease progression [5, 24]. This evidence concerns the gene APP and Alzheimer disease.